###begin article-title 0
Augmented TLR9-induced Btk activation in PIR-B-deficient B-1 cells provokes excessive autoantibody production and autoimmunity
###end article-title 0
###begin p 1
###xml 777 781 773 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 781 784 777 780 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 840 843 836 839 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 837 843 833 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fas<sup>lpr</sup></italic>
###xml 786 790 <span type="species:ncbi:10090">mice</span>
Pathogens are sensed by Toll-like receptors (TLRs) expressed in leukocytes in the innate immune system. However, excess stimulation of TLR pathways is supposed to be connected with provocation of autoimmunity. We show that paired immunoglobulin (Ig)-like receptor B (PIR-B), an immunoreceptor tyrosine-based inhibitory motif-harboring receptor for major histocompatibility class I molecules, on relatively primitive B cells, B-1 cells, suppresses TLR9 signaling via Bruton's tyrosine kinase (Btk) dephosphorylation, which leads to attenuated activation of nuclear factor kappaB p65RelA but not p38 or Erk, and blocks the production of natural IgM antibodies, including anti-IgG Fc autoantibodies, particularly rheumatoid factor. The autoantibody production in PIR-B-deficient (Pirb-/-) mice was further augmented in combination with the Faslpr mutation, which might be linked to the development of autoimmune glomerulonephritis. These results show the critical link between TLR9-mediated sensing and a simultaneously evoked, PIR-B-mediated inhibitory circuit with a Btk intersection in B-1 cells, and suggest a novel way toward preventing pathogenic natural autoantibody production.
###end p 1
###begin p 2
###xml 193 213 193 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">Baccala et al., 2007</xref>
###xml 215 233 215 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">Groom et al., 2007</xref>
###xml 235 257 235 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21">Krieg and Vollmer 2007</xref>
###xml 259 279 259 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib36">Rothlin et al., 2007</xref>
###xml 554 572 554 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">Akira et al., 2001</xref>
###xml 574 601 574 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib19">Iwasaki and Medzhitov, 2004</xref>
###xml 813 836 813 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">Marsland and Kopf, 2007</xref>
The emergence of autoimmunity is often coupled with aging, and is suggested to be linked to activation of the innate immune system in individuals suffering from bacterial and viral infections (Baccala et al., 2007; Groom et al., 2007; Krieg and Vollmer 2007; Rothlin et al., 2007). Toll-like receptors (TLRs) expressed in leukocytes of the innate immune system play indispensable roles in the sensing of viral and bacterial invasion through binding pathogen-associated molecular patterns, which leads to efficient T cell-mediated inflammatory responses (Akira et al., 2001; Iwasaki and Medzhitov, 2004). The TLR-mediated priming of inflammation and production of neutralizing antibodies against pathogens should be strictly regulated, otherwise there is the possibility of the development of autoimmune diseases (Marsland and Kopf, 2007). The mechanisms underlying the efficient TLR-mediated activation of the innate and adaptive immune systems with prevention of reactivity to autologous tissues remain elusive.
###end p 2
###begin p 3
###xml 326 329 326 329 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">low</sup>
###xml 332 336 332 336 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 340 341 340 341 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 345 346 345 346 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 349 352 349 352 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">low</sup>
###xml 360 384 360 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">Berland and Wortis, 2002</xref>
###xml 386 411 386 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib39">Tung and Herzenberg, 2007</xref>
###xml 573 596 573 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib34">Ochsenbein et al., 1999</xref>
###xml 701 723 701 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">Baumgarth et al., 2005</xref>
###xml 725 749 725 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">Carroll and Holers, 2005</xref>
###xml 947 968 947 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">Murakami et al., 1995</xref>
###xml 1065 1087 1065 1087 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">Gururajan et al., 2007</xref>
###xml 1244 1266 1244 1266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">Genestier et al., 2007</xref>
###xml 1282 1304 1282 1304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">Murakami et al. (1995)</xref>
###xml 1353 1368 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1462 1466 <span type="species:ncbi:10090">mice</span>
###xml 1730 1745 <span type="species:ncbi:10090">transgenic mice</span>
Examples of critical cells that express TLRs and could potentially link the innate and adaptive immune systems are relatively primitive B cells, B-1 cells, found mainly in the peritoneal and pleural cavities. In contrast to recirculating follicular B cells (or conventional B or B-2 cells), B-1 cells are characterized by B220lowIgMhighCD23-CD43+IgDlow cells (Berland and Wortis, 2002; Tung and Herzenberg, 2007). Although it has been pointed out by many researchers that innate B-1 cells but not conventional B cells are producers of natural antibodies against pathogens (Ochsenbein et al., 1999), accumulating lines of evidence suggest that a major source of autoantibodies is also those B-1 cells (Baumgarth et al., 2005; Carroll and Holers, 2005), but it has been a matter of debate. By stimulation via different TLRs, the B-1 cell population in the peritoneal cavity has been enlarged and B-1 cell-mediated autoantibody production augmented (Murakami et al., 1995). This could be partly because B-1 cells express a set of TLRs, including TLR4, TLR7, and TLR9 (Gururajan et al., 2007), and are more prone to differentiate into plasma cells than B-2 cells upon TLR-mediated stimulation, although B-2 cells similarly possess a range of TLRs (Genestier et al., 2007). For example, Murakami et al. (1995) have shown, in anti-red blood cell autoantibody transgenic mice, that the susceptibility to autoimmune hemolytic anemia was significantly increased when the mice were transferred from germ-free or specific pathogen-free conditions to conventional conditions or injected with a TLR4 ligand, LPS, with a concomitant increase in the peritoneal B-1 cell population, whereas almost all B-2 cells are constitutively deleted in the transgenic mice. These findings again suggest the importance of the regulation of TLR signaling in B-1 cells, which prevents overstimulation of TLRs so as not to evoke overproduction of natural antibodies, including potentially harmful autoantibodies. Therefore, what mechanisms may regulate the overstimulation of the TLR signal, particularly in B-1 cells?
###end p 3
###begin p 4
###xml 53 72 53 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib17">Hayami et al., 1997</xref>
###xml 74 95 74 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">Kubagawa et al., 1997</xref>
###xml 406 421 406 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">Ho et al., 1999</xref>
###xml 423 441 423 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib26">Maeda et al., 1999</xref>
###xml 609 628 609 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib29">Masuda et al., 2007</xref>
###xml 666 670 666 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 670 673 670 673 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 796 814 796 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib40">Ujike et al., 2002</xref>
###xml 675 679 <span type="species:ncbi:10090">mice</span>
###xml 790 794 <span type="species:ncbi:10090">mice</span>
We speculated that paired Ig-like receptor B (PIR-B; Hayami et al., 1997; Kubagawa et al., 1997) could participate in the regulation of B-1 cells. Recruitment of SH2 domain-containing tyrosine phosphatase 1 (SHP-1) to phosphotyrosylated immunoreceptor tyrosine-based inhibitory motifs (ITIMs) in the cytoplasmic portion of PIR-B was shown to be critical for PIR-B-mediated inhibitory signaling in general (Ho et al., 1999; Maeda et al., 1999), and this inhibition is achieved, at least in part, via constitutive binding of PIR-B to its ligand, i.e., MHC class I molecules, expressed on the same cell surface (Masuda et al., 2007). Interestingly, in PIR-B-deficient (Pirb-/-) mice, the peritoneal B-1 cell population significantly increased, particularly with aging, compared with wild-type mice (Ujike et al., 2002). However, it has not been determined how the B-1 cell compartment is physiologically regulated by PIR-B or what the physiological or pathological consequence of the expanded B-1 cells is in the contexts of infection and autoimmunity.
###end p 4
###begin p 5
###xml 638 641 638 641 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 635 641 635 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fas<sup>lpr</sup></italic>
###xml 669 673 669 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 673 676 673 676 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 679 682 679 682 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 676 682 676 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fas<sup>lpr</sup></italic>
###xml 690 694 <span type="species:ncbi:10090">mice</span>
In this paper, we show that PIR-B can inhibit TLR9-mediated signaling via regulation of Bruton's tyrosine kinase (Btk) phosphorylation in peritoneal B-1 cells. We found that TLR9 activation immediately activates an Src family kinase, Lyn, which then phosphorylates PIR-B cytoplasmic ITIMs. In the absence of PIR-B, B-1 cells become hyperproducers of natural IgM antibodies, including anti-IgG Fc autoantibodies, i.e., rheumatoid factor (RF), via unmethylated CpG-B oligodeoxynucleotide (CpG-B) stimulation in vitro and in vivo or upon aging. These phenotypes caused by PIR-B deficiency were further exaggerated in combination with the Faslpr mutation, which caused the Pirb-/-Faslpr mutant mice to be short-lived mainly because of autoimmune glomerulonephritis with immune complex depositions. Our findings may provide a novel strategy for preventing autoimmunity by reducing the production of pathogenic autoantibodies by B-1 cells, such as through down-regulation of Btk activation or enhancement of PIR-B-mediated B-1 cell regulation.
###end p 5
###begin title 6
RESULTS
###end title 6
###begin title 7
###xml 25 28 25 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 22 28 22 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fas<sup>lpr</sup></italic>
PIR-B deficiency with Faslpr mutation characteristically augments autoantibody production associated with autoimmune glomerulonephritis
###end title 7
###begin p 8
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 77 85 77 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 A</xref>
###xml 236 240 236 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 240 243 240 243 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 246 249 246 249 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 243 249 243 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fas<sup>lpr</sup></italic>
###xml 350 358 350 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 A</xref>
###xml 711 719 711 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 B</xref>
###xml 839 843 839 843 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 843 846 843 846 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 849 852 849 852 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 846 852 846 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fas<sup>lpr</sup></italic>
###xml 859 867 859 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 B</xref>
###xml 937 940 937 940 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 934 940 934 940 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fas<sup>lpr</sup></italic>
###xml 1291 1294 1291 1294 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 1288 1294 1288 1294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fas<sup>lpr</sup></italic>
###xml 1339 1343 1339 1343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 1343 1346 1343 1346 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1349 1352 1349 1352 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 1346 1352 1346 1352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fas<sup>lpr</sup></italic>
###xml 1359 1367 1359 1367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 C</xref>
###xml 1558 1562 1558 1562 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 1562 1565 1562 1565 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1568 1571 1568 1571 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 1565 1571 1565 1571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fas<sup>lpr</sup></italic>
###xml 1588 1591 1588 1591 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 1585 1591 1585 1591 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fas<sup>lpr</sup></italic>
###xml 1674 1682 1674 1682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 D</xref>
###xml 1894 1898 1888 1892 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 1898 1901 1892 1895 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1904 1907 1898 1901 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 1901 1907 1895 1901 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fas<sup>lpr</sup></italic>
###xml 1937 1940 1931 1934 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 1934 1940 1928 1934 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fas<sup>lpr</sup></italic>
###xml 1950 1958 1944 1952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 D</xref>
###xml 2115 2119 2106 2110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 2119 2122 2110 2113 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2125 2128 2116 2119 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 2122 2128 2113 2119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fas<sup>lpr</sup></italic>
###xml 2299 2307 2290 2298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 E</xref>
###xml 2339 2347 2330 2338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 E</xref>
###xml 2401 2405 2392 2396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 2405 2408 2396 2399 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2411 2414 2402 2405 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 2408 2414 2399 2405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fas<sup>lpr</sup></italic>
###xml 2586 2589 2577 2580 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 2583 2589 2574 2580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fas<sup>lpr</sup></italic>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
###xml 250 254 <span type="species:ncbi:10090">mice</span>
###xml 442 446 <span type="species:ncbi:10090">mice</span>
###xml 853 857 <span type="species:ncbi:10090">mice</span>
###xml 941 945 <span type="species:ncbi:10090">mice</span>
###xml 1136 1140 <span type="species:ncbi:10090">mice</span>
###xml 1295 1299 <span type="species:ncbi:10090">mice</span>
###xml 1353 1357 <span type="species:ncbi:10090">mice</span>
###xml 1572 1576 <span type="species:ncbi:10090">mice</span>
###xml 1908 1912 <span type="species:ncbi:10090">mice</span>
###xml 2139 2143 <span type="species:ncbi:10090">mice</span>
###xml 2415 2419 <span type="species:ncbi:10090">mice</span>
###xml 2494 2498 <span type="species:ncbi:10090">mice</span>
Pirb-/- mice were grossly normal and survived well to at least 50 wk of age (Fig. 1 A) without any abnormalities in the histology of their joint components (synovium and cartilage; ), skin, lungs, and glomeruli (not depicted). However, Pirb-/-Faslpr mice were found to be markedly short-lived, with only about half of them surviving at 40 wk of age (Fig. 1 A). Microscopic examination of their organ samples revealed that the combined mutant mice did not develop histopathological traits in the lung, salivary glands (not depicted), and joints (Fig. S1 A), but that in the kidney they readily developed diffuse glomerulopathy with a mild increase in the size and cellularity (mesangial area) of the glomerulus (Fig. 1 B, periodic acid-Schiff [PAS] stain). Immunofluorescence analysis revealed substantial deposition of IgG, IgM, and C3 in Pirb-/-Faslpr mice (Fig. 1 B). These pathological changes were not observed in wild-type B6 or Faslpr mice, indicating that autoimmune glomerulonephritis occurs as a combined effect of PIR-B and Fas mutations (Fig. S1 B). Consistent with no arthritis and Sjogren-like disease in the double-mutant mice, anti-SS-B/La antibodies were below the detection limit (Fig. S1 C, left). We also found that, although the levels of IgM- and IgG-RF were high in Faslpr mice, these levels were further elevated in Pirb-/-Faslpr mice (Fig. 1 C), indicating that PIR-B deficiency has a marked impact on the augmentation of RF production in vivo. In addition, anti-double-stranded (ds) DNA autoantibody production was more augmented in Pirb-/-Faslpr mice than in Faslpr animals, although the difference did not reach a statistically significant level (Fig. 1 D). We also measured by ELISA the levels of autoantibodies in sera against single-stranded (ss) DNA and beta2-glycoprotein I (beta2-GPI), but we did not observe a significant elevation of anti-ssDNA production in Pirb-/-Faslpr mice tested compared with Faslpr animals (Fig. 1 D, right), nor we did not detect anti-beta2-GPI (Fig. S1 C, right). Examinations of hematocrit values failed to demonstrate an autoimmune hemolytic anemia in Pirb-/-Faslpr and other mice (). The PIR-B deficiency did not result in any obvious changes in the staining pattern by antinuclear autoantibodies (Fig. S1 D). The peritoneal B-1 cell (Fig. 1 E, top) and splenic plasma cell (Fig. 1 E, bottom) populations were also markedly increased in Pirb-/-Faslpr mice. With these data collectively, we concluded that PIR-B deficiency renders mice susceptible to the development of autoimmune glomerulonephritis in combination with Faslpr, which accompanies with a markedly elevated RF production, with a robust production of anti-dsDNA and anti-ssDNA autoantibodies.
###end p 8
###begin p 9
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 20 23 20 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 17 23 17 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fas<sup>lpr</sup></italic>
###xml 0 136 0 136 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>Pirb</italic><sup>&#8722;/&#8722;</sup> with the <italic>Fas<sup>lpr</sup></italic> mutation is sufficient in mice for the development of glomerulonephritis with marked elevation of RF production.</bold>
###xml 141 145 141 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 145 148 145 148 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 151 154 151 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 148 154 148 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fas<sup>lpr</sup></italic>
###xml 232 236 232 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 236 239 236 239 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 242 245 242 245 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 239 245 239 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fas<sup>lpr</sup></italic>
###xml 247 248 247 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 277 280 277 280 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 274 280 274 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fas<sup>lpr</sup></italic>
###xml 282 283 282 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 294 298 294 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 298 301 298 301 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 303 304 303 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 320 321 320 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 367 371 367 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 371 374 371 374 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 377 380 377 380 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 374 380 374 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fas<sup>lpr</sup></italic>
###xml 882 886 878 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 886 889 882 885 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 892 895 888 891 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 889 895 885 891 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fas<sup>lpr</sup></italic>
###xml 918 921 914 917 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 915 921 911 917 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fas<sup>lpr</sup></italic>
###xml 1036 1037 1030 1031 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1187 1188 1181 1182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1329 1333 1323 1327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 1333 1336 1327 1330 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1339 1342 1333 1336 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 1336 1342 1330 1336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fas<sup>lpr</sup></italic>
###xml 1372 1375 1366 1369 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 1369 1375 1363 1369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fas<sup>lpr</sup></italic>
###xml 1547 1548 1539 1540 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1731 1732 1723 1724 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1847 1851 1839 1843 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 1851 1854 1843 1846 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1857 1860 1849 1852 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 1854 1860 1846 1852 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fas<sup>lpr</sup></italic>
###xml 1960 1961 1952 1953 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1964 1965 1956 1957 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1968 1969 1960 1961 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 2062 2066 2054 2058 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 2066 2069 2058 2061 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2281 2282 2273 2274 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2286 2287 2278 2279 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2290 2291 2282 2283 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 2294 2295 2286 2287 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 50 54 <span type="species:ncbi:10090">mice</span>
###xml 155 159 <span type="species:ncbi:10090">mice</span>
###xml 254 258 <span type="species:ncbi:10090">mice</span>
###xml 328 332 <span type="species:ncbi:10090">mice</span>
###xml 381 385 <span type="species:ncbi:10090">mice</span>
###xml 573 577 <span type="species:ncbi:10090">mice</span>
###xml 640 645 <span type="species:ncbi:10090">mouse</span>
###xml 714 718 <span type="species:ncbi:10090">mice</span>
###xml 896 900 <span type="species:ncbi:10090">mice</span>
###xml 922 926 <span type="species:ncbi:10090">mice</span>
###xml 959 963 <span type="species:ncbi:10090">mice</span>
###xml 1042 1046 <span type="species:ncbi:10090">mice</span>
###xml 1343 1347 <span type="species:ncbi:10090">mice</span>
###xml 1376 1380 <span type="species:ncbi:10090">mice</span>
###xml 1419 1423 <span type="species:ncbi:10090">mice</span>
###xml 1553 1557 <span type="species:ncbi:10090">mice</span>
###xml 1861 1865 <span type="species:ncbi:10090">mice</span>
###xml 1908 1912 <span type="species:ncbi:10090">mice</span>
###xml 2070 2074 <span type="species:ncbi:10090">mice</span>
###xml 2221 2225 <span type="species:ncbi:10090">mice</span>
###xml 2397 2401 <span type="species:ncbi:10090">mice</span>
Pirb-/- with the Faslpr mutation is sufficient in mice for the development of glomerulonephritis with marked elevation of RF production. (A) Pirb-/-Faslpr mice were remarkably short-lived. The survival curves for male and female B6.Pirb-/-Faslpr (n = 20 mice per group), B6.Faslpr (n = 20), B6.Pirb-/- (n = 20), and B6 (n = 20) mice until 50 wk of age are shown. (B) Pirb-/-Faslpr mice develop diffuse glomerulonephritis with a mild increase in the size and cellularity of the glomerulus, and depositions of IgG, IgM, and complement C3. Kidney sections from each strain of mice at 24 wk of age were stained with PAS or Alexa Fluor 488 anti-mouse IgG, IgM, and C3. Each panel is representative of samples from five mice per group with similar staining profiles in a single staining experiment. Bars, 10 microm. (C) Both the IgM- and IgG-RF levels were significantly more elevated in Pirb-/-Faslpr mice than those in Faslpr mice. RF in sera from each strain of mice at 24 wk of age was measured by ELISA. Data are shown as means +/- SEM (n = 8 mice per group) and are representative of three separate experiments with similar results. Statistical analyses were performed using a Student's t test. *, P < 0.05; **, P < 0.01. (D) The anti-dsDNA and anti-ssDNA autoantibody levels were augmented but not significantly elevated in the Pirb-/-Faslpr mice tested compared with Faslpr mice. Anti-DNA in sera from each strain of mice at 24 wk of age for anti-dsDNA or at 4-10 mo of age for anti-ssDNA was measured by ELISA. Data are shown as means +/- SEM (n = 8 mice per group) and are representative of three (anti-dsDNA) or two (anti-ssDNA) separate experiments with similar results. Statistical analyses were performed using a Student's t test. *, P < 0.05; **, P < 0.01. (E) Markedly enlarged peritoneal B-1 cell and splenic plasma cell populations in Pirb-/-Faslpr mice. Peritoneal cells isolated from 24-wk-old mice were stained with anti-B220, CD5, and CD3. B220+CD5+CD3- B-1 cells (circled) with the percentages are shown (top). Staining of peritoneal cells from Pirb-/- mice with anti-CD19, instead of B220, gave a B-1 cell population with a similar size (not depicted in the figure). Splenocytes isolated from 24-wk-old mice were stained with anti-CD138, B220, IgM, and IgD. CD138+B220+IgM-IgD- plasma cells (circled) with the percentages are shown (bottom). The figure is representative of five mice per group.
###end p 9
###begin title 10
###xml 26 30 26 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 30 33 30 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 34 38 <span type="species:ncbi:10090">mice</span>
Elevated RF production in Pirb-/- mice administered with CpG-B DNA
###end title 10
###begin p 11
###xml 198 237 198 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">Montecino-Rodriguez and Dorshkind, 2006</xref>
###xml 489 510 489 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">Murakami et al., 1995</xref>
###xml 512 530 512 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">Akira et al., 2001</xref>
###xml 532 550 532 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">De Re et al., 2006</xref>
###xml 552 575 552 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21">Krieg and Vollmer, 2007</xref>
###xml 577 600 577 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">Marsland and Kopf, 2007</xref>
###xml 697 701 697 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 701 704 701 704 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 764 767 764 767 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 761 767 761 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fas<sup>lpr</sup></italic>
###xml 882 886 882 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 886 889 886 889 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 996 1004 996 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 A</xref>
###xml 1100 1104 1100 1104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 1104 1107 1104 1107 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1269 1273 1269 1273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 1273 1276 1273 1276 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1297 1305 1297 1305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 B</xref>
###xml 1481 1502 1481 1502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">Murakami et al., 1995</xref>
###xml 1620 1624 1620 1624 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 1624 1627 1624 1627 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1671 1679 1671 1679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 C</xref>
###xml 1775 1779 1775 1779 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 1779 1782 1779 1782 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 705 709 <span type="species:ncbi:10090">mice</span>
###xml 817 821 <span type="species:ncbi:10090">mice</span>
###xml 890 894 <span type="species:ncbi:10090">mice</span>
###xml 1108 1112 <span type="species:ncbi:10090">mice</span>
###xml 1291 1295 <span type="species:ncbi:10090">mice</span>
###xml 1628 1632 <span type="species:ncbi:10090">mice</span>
###xml 1665 1669 <span type="species:ncbi:10090">mice</span>
###xml 1783 1787 <span type="species:ncbi:10090">mice</span>
RF is one of the autoreactive natural antibodies whose primary role is believed to be the first-line defense against infection. The main source of such autoantibodies is considered to be B-1 cells (Montecino-Rodriguez and Dorshkind, 2006). Adequate regulation of the production of natural autoantibodies, including RF, is proposed to be crucial for avoiding autoimmune diseases, which are otherwise evoked by too strong or sustained innate responses against microbial or viral infections (Murakami et al., 1995; Akira et al., 2001; De Re et al., 2006; Krieg and Vollmer, 2007; Marsland and Kopf, 2007). To characterize the precise sources of RF, we next examined the RF levels in sera from B6 and Pirb-/- mice in the absence of a potentially large influence by Faslpr mutation. Although 8- and 40-wk-old B6 wild-type mice did not show notable production of either IgM-RF or IgG-RF, Pirb-/- mice at 40 wk of age exhibited significantly higher levels of IgM-RF and slightly elevated IgG-RF levels (Fig. 2 A). When we intraperitoneally injected 3 nmol CpG-B DNA, a ligand for TLR9, into 8-wk-old B6 and Pirb-/- mice, and determined IgM-RF and IgG-RF levels in their sera after 48 and 120 h, respectively, we found that the RF of both classes was significantly elevated in Pirb-/- but not in B6 mice (Fig. 2 B), suggesting that CpG-B-responsive cells in the peritoneal cavity produce RF. Diminishing B-1 cells, as well as B-2 cells, in the peritoneum by repeated injection of water (; Murakami et al., 1995) resulted in a significant reduction of the total IgM level and a nearly complete abrogation of IgM-RF production in Pirb-/- mice comparable to that in wild-type mice (Fig. 2 C). These results suggest that peritoneal B cells are a major source of IgM-RF autoantibodies in Pirb-/- mice.
###end p 11
###begin p 12
###xml 26 30 26 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 30 33 30 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 0 39 0 39 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Enhanced RF production in <italic>Pirb</italic><sup>&#8722;/&#8722;</sup> mice.</bold>
###xml 92 96 92 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 96 99 96 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 153 157 153 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 157 160 157 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 291 292 289 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 442 443 440 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 524 528 522 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 528 531 526 529 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 607 611 605 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 611 614 609 612 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 829 830 825 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 980 981 976 977 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1069 1073 1065 1069 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 1073 1076 1069 1072 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1230 1251 1226 1247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">Murakami et al., 1995</xref>
###xml 1391 1395 1387 1391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 1395 1398 1391 1394 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1438 1439 1432 1433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1589 1590 1583 1584 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 34 38 <span type="species:ncbi:10090">mice</span>
###xml 106 110 <span type="species:ncbi:10090">mice</span>
###xml 161 165 <span type="species:ncbi:10090">mice</span>
###xml 297 301 <span type="species:ncbi:10090">mice</span>
###xml 532 536 <span type="species:ncbi:10090">mice</span>
###xml 615 619 <span type="species:ncbi:10090">mice</span>
###xml 835 839 <span type="species:ncbi:10090">mice</span>
###xml 1077 1081 <span type="species:ncbi:10090">mice</span>
###xml 1399 1403 <span type="species:ncbi:10090">mice</span>
###xml 1444 1448 <span type="species:ncbi:10090">mice</span>
Enhanced RF production in Pirb-/- mice. (A) The IgM-RF levels are significantly elevated in Pirb-/-, aged mice in particular. Sera from wild-type B6 and Pirb-/- mice at 8 and 40 wk of age were subjected to measurement of the IgM- and IgG-RF levels by ELISA. Data are shown as means +/- SEM (n = 5 mice per group) and are representative of three separate experiments with similar results. Statistical analyses were performed using a Student's t test. *, P < 0.05. (B) Both the IgM- and IgG-RF levels in sera were elevated in Pirb-/- mice after CpG-B administration into the peritoneum of the animals. B6 and Pirb-/- mice at 8 wk of age were injected with 3 nmol CpG-B into the peritoneal cavity. Serum samples collected after 48 and 120 h were analyzed by ELISA for IgM- and IgG-RF, respectively. Data are shown as means +/- SEM (n = 4 mice per group) and are representative of three separate experiments with similar results. Statistical analyses were performed using a Student's t test. *, P < 0.05. (C) IgM-RF is produced preferentially by peritoneal B cells. B6 and Pirb-/- mice at 5 wk of age were injected intraperitoneally with water or PBS as a negative control to achieve relatively specific elimination of the B-1 cells (Murakami et al., 1995). After four rounds of water injection, the total IgM level was significantly decreased and the IgM-RF was substantially lost in sera from Pirb-/- mice. Data are shown as means +/- SEM (n = 3 mice per group) and are representative of three separate experiments with similar results. Statistical analyses were performed using a Student's t test. *, P < 0.05.
###end p 12
###begin title 13
Augmented CpG-B responses in PIR-B-deficient B-1 cells in vitro
###end title 13
###begin p 14
###xml 127 128 127 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 133 134 133 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 177 181 177 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 181 184 181 184 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 303 307 303 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 307 310 307 310 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 449 457 449 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 A</xref>
###xml 563 585 563 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">Gururajan et al., 2007</xref>
###xml 627 631 627 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 631 634 631 634 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 820 824 820 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 824 827 824 827 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 878 886 878 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 B</xref>
###xml 918 926 918 926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 B</xref>
###xml 964 968 964 968 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 968 971 968 971 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1463 1481 1463 1481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib26">Maeda et al., 1999</xref>
###xml 185 189 <span type="species:ncbi:10090">mice</span>
###xml 311 315 <span type="species:ncbi:10090">mice</span>
###xml 1120 1124 <span type="species:ncbi:10090">mice</span>
Next, we aimed at examining more precisely the PIR-B-mediated regulation of RF production by B-1 cells in vitro. We sorted B220+CD11b+ B-1 cells from peritoneal cells of B6 and Pirb-/- mice, and examined them for their proliferation upon stimulation with various TLR ligands. B-1 cells from both B6 and Pirb-/- mice were found to respond well to LPS (TLR4 ligand) and CpG-B (TLR9 ligand), but not to poly(I:C) (TLR3 ligand) or ssRNA (TLR7/8 ligand; Fig. 3 A), indicating the significant roles of TLR4 and TLR9 in the B-1 cell function, as pointed out previously (Gururajan et al., 2007). Interestingly, however, stimulation of Pirb-/- B-1 cells with CpG-B provoked higher proliferation than that of wild-type cells, whereas the LPS-mediated responses were comparable. The CpG-B-mediated augmented proliferation seen for Pirb-/- B-1 cells was not observed for splenic B-2 cells (Fig. 3 B, left), as in the case of LPS (Fig. 3 B, right). These results indicate that Pirb-/- peritoneal B-1 cells, but not the splenic B-2 cells, were more sensitive to CpG-B stimulation and divided more vigorously than those from wild-type mice. We observed that B-1 cells express about sixfold more PIR-B molecules on their surface than splenic B-2 cells, whereas the TLR9 expression levels are comparable between B-1 and B-2 cells when estimated by flow cytometry (Fig. S2, A and B). We also noted that the expression level of Btk, one of the signal mediators downstream of PIR-B (Maeda et al., 1999), is higher in B-1 cells than that in B-2 cells (Fig. S3, C and D). These observations may account for, at least partly, the difference in the sensitivity to CpG-B between B-1 and B-2 cells.
###end p 14
###begin p 15
###xml 48 52 48 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 52 55 52 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 0 93 0 93 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Enhanced responses in peritoneal B-1 cells from <italic>Pirb</italic><sup>&#8722;/&#8722;</sup> mice upon CpG-B stimulation in vitro.</bold>
###xml 193 197 193 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 197 200 197 200 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 207 208 207 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 314 315 314 315 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 693 697 691 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 697 700 695 698 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 707 708 705 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1030 1031 1022 1023 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 56 60 <span type="species:ncbi:10090">mice</span>
###xml 201 205 <span type="species:ncbi:10090">mice</span>
###xml 701 705 <span type="species:ncbi:10090">mice</span>
Enhanced responses in peritoneal B-1 cells from Pirb-/- mice upon CpG-B stimulation in vitro. (A and B) Proliferation of peritoneal B-1 cells (A) or splenic B-2 cells (B) from wild-type B6 and Pirb-/- mice (n = 5 per group) with various stimuli. Peritoneal B-1 cells and splenic B-2 cells were pulse labeled with [3H]thymidine during the last 8 h of the 48-h culture period with or without a stimulant. Data are shown as means +/- SEM of triplicate cultures and are representative of three independent experiments. Statistical analyses were performed using two-way analysis of variance. ***, P < 0.001. (C) Production of Igs, autoantibodies, and a cytokine by peritoneal B-1 cells from B6 and Pirb-/- mice (n = 5 per group). B-1 cells were stimulated with 1 microM CpG-B or GpC control, and assessed for total IgM, IgM-RF, IgG-RF, anti-dsDNA, and IL-10 by ELISA. Data are shown as means +/- SEM of triplicate cultures, and are representative of three independent experiments. Statistical analyses were performed using a Student's t test. ***, P < 0.001. Provided standard and assay diluent supplemented in the ELISA kit were served as positive control (Pc) and negative control (Nc), respectively.
###end p 15
###begin p 16
###xml 36 40 36 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 40 43 40 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 119 141 119 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">Baumgarth et al., 2005</xref>
###xml 143 167 143 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">Carroll and Holers, 2005</xref>
###xml 169 191 169 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">Gururajan et al., 2007</xref>
###xml 409 417 405 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 C</xref>
###xml 538 542 534 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 542 545 538 541 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 641 645 637 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 645 648 641 644 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1046 1050 1042 1046 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 1050 1053 1046 1049 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
This observation of CpG-B-sensitive Pirb-/- B-1 cells prompted us to examine whether other possible B-1 cell products (Baumgarth et al., 2005; Carroll and Holers, 2005; Gururajan et al., 2007) could also be elevated. A culture supernatant was collected after a 20-72-h stimulation of B-1 cells with 1 microM CpG-B, which was subjected to measurement of the contents of autoantibodies and a cytokine by ELISA (Fig. 3 C). We found that total IgM, IgM-RF, and IL-10 release, but not IgG-RF or anti-dsDNA, were significantly more elevated in Pirb-/- B-1 cells than in wild-type cells. Collectively, these data indicate that CpG-B stimulation of Pirb-/- peritoneal B-1 cells resulted in augmented proliferation, enhanced IgM antibody production (including autoreactive IgM-RF), and IL-10 release in vitro. Although B-1 cells express PIR-B molecules more abundantly on their surface than splenic B-2 cells (Fig. S3 A), the expression of PIR-A, an activating counterpart of PIR-B, is not detected on B-1 cells (), and the TLR9 level is not augmented in Pirb-/- B-1 cells (Fig. S4 C), suggestive of the presence of any PIR-B-mediated inhibitory signaling that specifically regulates TLR9 in B-1 cells.
###end p 16
###begin title 17
Augmented phosphorylation of PIR-B and SHP-1 recruitment upon CpG-B stimulation of B-1 cells
###end title 17
###begin p 18
###xml 436 444 436 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 A</xref>
###xml 618 633 618 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4, B and C</xref>
###xml 676 691 676 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">Ho et al., 1999</xref>
###xml 693 714 693 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib23">Kubagawa et al., 1999</xref>
###xml 716 734 716 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib26">Maeda et al., 1999</xref>
###xml 836 855 836 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib29">Masuda et al., 2007</xref>
###xml 1050 1058 1050 1058 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 B</xref>
###xml 1244 1252 1244 1252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 C</xref>
###xml 1317 1325 1317 1325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 C</xref>
###xml 1580 1588 1580 1588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 C</xref>
Because of the very limited number of purified B-1 cells that we can sort from peritoneal cells, we used whole peritoneal cells or cultured macrophages, which give a grossly similar PIR-B signal upon CpG-B stimulation as B-1 cells (unpublished data), in some analyses of signaling events. PIR-B phosphorylation in peritoneal cells was augmented, reached a maximum as early as 5 min after CpG-B addition, and lasted for at least 20 min (Fig. 4 A). Notably, PIR-B in peritoneal cells in the nonstimulated state was already tyrosine phosphorylated, as in the cases of other cells such as splenic B cells and macrophages (Fig. 4, B and C, B-1 cells and macrophages, respectively; Ho et al., 1999; Kubagawa et al., 1999; Maeda et al., 1999), possibly because of constitutive PIR-B ligation to MHC class I molecules on the same cell surface (Masuda et al., 2007). CpG-B-induced augmentation of PIR-B phosphorylation indeed also occurred in purified B-1 cells 5 min after the stimulation, and was accompanied by a significant increase in SHP-1 recruitment (Fig. 4 B). Importantly, although we also found augmented phosphorylation of PIR-B and enhanced recruitment of SHP-1 upon stimulation of cultured macrophages with CpG-B, but not GpC control DNA (Fig. 4 C, left), these events were not observed in TLR9-deficient cells (Fig. 4 C, right), indicating that CpG-B-mediated PIR-B phosphorylation is dependent on TLR9. Interestingly, stimulation of macrophages with CpG-B but not GpC induced coprecipitation of PIR-B and Lyn, whereas the stimulation of TLR9-deficient macrophages did not (Fig. 4 C, second from bottom), suggestive of an interaction of Lyn and PIR-B upon TLR9 activation (see following paragraph).
###end p 18
###begin p 19
###xml 0 115 0 115 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Augmented phosphorylation of PIR-B and enhanced recruitment of SHP-1 in peritoneal B-1 cells stimulated with CpG-B.</bold>
###xml 201 205 201 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 205 208 205 208 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 215 216 215 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 743 744 739 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1202 1206 1194 1198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tlr9</italic>
###xml 1206 1209 1198 1201 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1224 1225 1216 1217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 209 213 <span type="species:ncbi:10090">mice</span>
###xml 737 741 <span type="species:ncbi:10090">mice</span>
###xml 1170 1174 <span type="species:ncbi:10090">mice</span>
###xml 1211 1215 <span type="species:ncbi:10090">mice</span>
Augmented phosphorylation of PIR-B and enhanced recruitment of SHP-1 in peritoneal B-1 cells stimulated with CpG-B. (A) Time course of tyrosine phosphorylation of PIR-B in peritoneal cells from B6 and Pirb-/- mice (n = 8 per group) stimulated with CpG-B. After stimulation with 1 microM CpG-B, samples were taken at various time points and first immunoprecipitated (IP) with anti-PIR-B and then immunoblotted (IB) to visualize PIR-B phosphotyrosine (top), followed by reprobing with anti-PIR-B (bottom). Data are representative of three separate experiments with similar results. (B) Augmented tyrosine phosphorylation of PIR-B and enhanced recruitment of SHP-1 in peritoneal B-1 cells stimulated with CpG-B. B-1 cells from wild-type B6 mice (n = 12) were stimulated with 1 microM CpG-B and subjected to immunoprecipitation and protein blot analysis (IP-Western) to visualize the phosphotyrosylation of PIR-B (top), SHP-1 (middle), and PIR-B (bottom). Data are representative of three separate experiments with similar results. (C) Phosphotyrosylation of PIR-B upon CpG stimulation is dependent on TLR9. Bone marrow-derived cultured macrophages (BMMs) from wild-type B6 mice (left) and TLR9-deficient (Tlr9-/-) mice (right; n = 4 per group) were stimulated with 1 microM CpG-B or GpC control DNA, and subjected to IP-Western to visualize phosphotyrosylated PIR-B (top), SHP-1 (second from top), Lyn (second from bottom; arrow), and PIR-B (bottom). Data are representative of three separate experiments with similar results. The intensity for each band was estimated by densitometric scanning with normalization as to loading control.
###end p 19
###begin title 20
Up-regulated phosphorylation of PIR-B is mediated, at least partly, by Lyn
###end title 20
###begin p 21
###xml 141 156 141 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">Ho et al., 1999</xref>
###xml 509 524 509 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5, A and B</xref>
###xml 615 630 615 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5, C and D</xref>
###xml 783 791 783 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 C</xref>
Preceding studies by others indicated that, in splenic B cells, Lyn is the major Src family kinase that constitutively phosphorylates PIR-B (Ho et al., 1999). To elucidate the molecular mechanisms underlying TLR9-mediated PIR-B phosphorylation, we first examined activation of Lyn in TLR9-sufficient or -deficient B-1 cells stimulated with CpG-B. The phosphorylation level of Lyn was found to be augmented as early as 5 min after CpG-B stimulation of B-1 cells regardless of the presence or absence of PIR-B (Fig. 5, A and B). However, augmented phosphorylation of Lyn was not observed in TLR9-deficient B-1 cells (Fig. 5, C and D). In addition, as noted in the previous paragraph, Lyn-PIR-B coprecipitation was detected in a macrophage lysate prepared after stimulation with CpG-B (Fig. 4 C, second from bottom). These results indicate that Lyn is rapidly activated downstream of TLR9 and strongly suggest that Lyn is a candidate, if not the sole, Src family kinase that phosphorylates PIR-B.
###end p 21
###begin p 22
###xml 76 80 76 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 80 83 80 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 102 106 102 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tlr9</italic>
###xml 106 109 106 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 0 116 0 116 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Up-regulated phosphorylation of Lyn upon CpG-B stimulation of wild-type and <italic>Pirb</italic><sup>&#8722;/&#8722;</sup> B-1 cells but not <italic>Tlr9</italic><sup>&#8722;/&#8722;</sup> cells.</bold>
###xml 170 174 170 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 174 177 174 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 184 185 184 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 688 692 682 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tlr9</italic>
###xml 692 695 686 689 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 702 703 696 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1037 1041 1027 1031 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tlr9</italic>
###xml 1041 1044 1031 1034 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 178 182 <span type="species:ncbi:10090">mice</span>
###xml 696 700 <span type="species:ncbi:10090">mice</span>
Up-regulated phosphorylation of Lyn upon CpG-B stimulation of wild-type and Pirb-/- B-1 cells but not Tlr9-/- cells. (A and B) Peritoneal B-1 cells from wild-type B6 and Pirb-/- mice (n = 12 per group) were stimulated with 1 microM CpG-B and subjected to IP-Western analysis to visualize the phosphprylated Lyn (A). The phosphorylation levels of Lyn were estimated by densitometric scanning with normalization as to loading control and are depicted as a bar graph (B). Lyn phosphorylation was augmented upon CpG stimulation regardless of the presence or absence of PIR-B. Data are shown as means +/- SEM of three separate experiments. (C and D) Peritoneal B-1 cells from wild-type B6 and Tlr9-/- mice (n = 12 per group) were stimulated with 1 microM CpG-B and subjected to IP-Western analysis to visualize the phosphorylated Lyn (C). The phosphorylation levels of Lyn were estimated by densitometric scanning with normalization as to loading control and are depicted as a bar graph (D). Augmented Lyn phosphorylation was not observed in Tlr9-/- B-1 cells. Data are shown as means +/- SEM of three separate experiments. Control bands of Lyn (approximately56 kD) were obscured by 40-60-kD diffuse bands originated from protein A released from immunoprecipitation beads. *, P < 0.05.
###end p 22
###begin title 23
Enhanced activation of NF-kappaB but not the mitogen-activated protein kinase (MAPK) pathway in PIR-B-deficient B-1 cells after CpG-B stimulation
###end title 23
###begin p 24
###xml 138 142 138 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 142 145 142 145 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 254 272 250 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">Akira et al., 2001</xref>
###xml 274 294 270 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">Baccala et al., 2007</xref>
###xml 296 319 292 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21">Krieg and Vollmer, 2007</xref>
###xml 483 487 479 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 487 490 483 486 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 502 513 498 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6, A&#8211;C</xref>
###xml 785 789 777 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 789 792 781 784 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 843 858 835 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6, A and D</xref>
Next we aimed at elucidating the molecular events occurring in two major downstream cascades of TLR9 activation upon CpG-B stimulation of Pirb-/- B-1 cells. Generally, TLR9-mediated signaling leads to activation of NF-kappaB as well as the MAPK pathway (Akira et al., 2001; Baccala et al., 2007; Krieg and Vollmer, 2007). We observed that the phosphorylation levels of p38 MAPK and Erk were significantly augmented, particularly at 30 min after CpG-B addition, in both wild-type and Pirb-/- B-1 cells (Fig. 6, A-C). However, the phosphorylation kinetics and levels were comparable between these cells, suggesting that these phosphorylation events are independent of PIR-B-mediated regulation. Interestingly, however, p65 NF-kappaB phosphorylation was found to be markedly augmented in Pirb-/- B-1 cells as early as 5 min after CpG-B addition (Fig. 6, A and D). These results indicate that the NF-kappaB p65RelA subunit could be the target molecule located the most downstream of regulation through Lyn-mediated PIR-B phosphorylation, whereas the MAPK pathway is not linked to the PIR-B pathway.
###end p 24
###begin p 25
###xml 131 135 127 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 135 138 131 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 0 149 0 145 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p38 and Erk phosphorylation is not grossly influenced by PIR-B, whereas NF-&#954;B p65RelA phosphorylation is markedly augmented in <italic>Pirb</italic><sup>&#8722;/&#8722;</sup> B-1 cells.</bold>
###xml 293 297 289 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 297 300 293 296 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 307 308 303 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 470 474 466 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 474 477 470 473 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 558 562 550 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 562 565 554 557 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 301 305 <span type="species:ncbi:10090">mice</span>
p38 and Erk phosphorylation is not grossly influenced by PIR-B, whereas NF-kappaB p65RelA phosphorylation is markedly augmented in Pirb-/- B-1 cells. (A-D) Immunoblot analysis of phospho-p38, phospho-Erk, and phospho-p65RelA after CpG stimulation of peritoneal B-1 cells from wild-type B6 and Pirb-/- mice (n = 10-14 per group). Although the time courses and augmentation magnitudes of the phosphorylation of p38 and Erk were not grossly different between wild-type and Pirb-/- B-1 cells (A-C), phosphorylation of NF-kappaB p65RelA was markedly augmented in Pirb-/- B-1 cells (A and D). The intensity for each band was estimated by densitometric scanning with normalization as to loading control. Data are shown as means +/- SEM of three separate experiments. *, P < 0.05.
###end p 25
###begin title 26
Btk can link the PIR-B pathway and NF-kappaB cascade
###end title 26
###begin p 27
###xml 134 153 130 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib26">Maeda et al. (1999)</xref>
###xml 577 581 573 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 581 584 577 580 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 596 611 592 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7, A and B</xref>
###xml 839 843 835 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 843 846 839 842 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 959 963 955 959 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 963 966 959 962 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 978 993 974 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7, A and C</xref>
Which molecule acts as an intersection between the PIR-B-SHP-1-initiated inhibitory signaling pathway and the TLR9-NF-kappaB cascade? Maeda et al. (1999) reported that, in a B cell line, IIA1.6, Syk, and Btk were the substrates for SHP-1 recruited to PIR-B ITIMs upon stimulation of B cell receptors. This observation prompted us to examine the possible involvement of these two molecules in the TLR9 pathway. Examination of the phosphorylation status of Syk upon CpG-B addition to B-1 cells did not reveal significant enhancement of the phosphorylation in either wild-type or Pirb-/- B-1 cells (Fig. 7, A and B), indicating that Syk does not seem to be a critical substrate for SHP-1 recruited to PIR-B ITIMs in B-1 cells. Instead, we found that Btk phosphorylation was markedly augmented 5 min after CpG-B addition in both wild-type and Pirb-/- B-1 cells, and the augmentation did not show a marked decrease at least up to 30 min after CpG-B stimulation in Pirb-/- B-1 cells (Fig. 7, A and C), indicating that Btk is a major substrate for SHP-1.
###end p 27
###begin p 28
###xml 86 90 86 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 90 93 90 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 0 104 0 104 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Phosphorylation of Btk but not Syk is markedly up-regulated upon CpG-B stimulation of <italic>Pirb</italic><sup>&#8722;/&#8722;</sup> B-1 cells.</bold>
###xml 144 148 144 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 148 151 148 151 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 158 159 158 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 152 156 <span type="species:ncbi:10090">mice</span>
Phosphorylation of Btk but not Syk is markedly up-regulated upon CpG-B stimulation of Pirb-/- B-1 cells. (A-C) Peritoneal B-1 cells from B6 and Pirb-/- mice (n = 10-14 per group) were stimulated with 1 microM CpG-B and subjected to immunoblot analysis for visualization of phospho-Syk and phospho-Btk (A), which was estimated by densitometric scanning with normalization as to actin (B and C). Data are shown as means +/- SEM of three separate experiments. *, P < 0.05.
###end p 28
###begin title 29
Pretreatment of B-1 cells with Src family kinase inhibitors can suppress phosphorylation of Btk and NF-kappaB p65RelA after CpG-B stimulation
###end title 29
###begin p 30
###xml 455 470 447 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig8">Fig. 8, A and B</xref>
###xml 561 576 549 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig8">Fig. 8, A and C</xref>
To verify that Lyn could be the most upstream effector for Btk and NF-kappaB p65RelA phosphorylation, wild-type B-1 cells were pretreated with Src family kinase inhibitors (SU6656 or PP2), stimulated with CpG-B, and examined to determine the phosphorylation levels of Btk and NF-kappaB p65RelA. We observed that a slight increase in the phosphorylation level of Btk 5 min after CpG-B stimulation was partially blocked by pretreatment with the inhibitors (Fig. 8, A and B). The reduction of the phosphorylation was more evident in the case of NF-kappaB p65RelA (Fig. 8, A and C). These results indicate that Btk phosphorylation is dependent, at least partly, on an Src family kinase, most likely Lyn, and that NF-kappaB p65RelA phosphorylation is also a critical event downstream of Src family kinase activation.
###end p 30
###begin p 31
###xml 0 133 0 129 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CpG-B&#8211;induced phosphorylation of Btk and NF-&#954;B p65RelA in peritoneal B-1 cells is down-regulated by Src family kinase inhibitors.</bold>
###xml 185 186 181 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 179 183 <span type="species:ncbi:10090">mice</span>
CpG-B-induced phosphorylation of Btk and NF-kappaB p65RelA in peritoneal B-1 cells is down-regulated by Src family kinase inhibitors. (A-C) Peritoneal B-1 cells from wild-type B6 mice (n = 12) were treated with 10 microM SU6656 or PP2 for 30 min before stimulation with 1 microM CpG-B. 5 min later, cell lysates were subjected to immunoblot analysis to visualize the phosphorylation of Btk (top), NF-kappaB p65RelA (middle), and loading control beta-actin (bottom; A). The phosphorylation levels of Btk and p65RelA were estimated by densitometric scanning with normalization as to actin and are depicted as bar graphs (B and C). Data are representative of three separate experiments with similar results.
###end p 31
###begin title 32
DISCUSSION
###end title 32
###begin p 33
###xml 96 116 96 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib36">Rothlin et al., 2007</xref>
###xml 125 146 125 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib42">Whitmore et al., 2007</xref>
###xml 156 175 156 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib28">Martin et al., 2007</xref>
###xml 189 204 189 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">An et al., 2008</xref>
###xml 420 440 420 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib36">Rothlin et al., 2007</xref>
###xml 878 893 878 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">Ho et al., 1999</xref>
###xml 895 916 895 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib23">Kubagawa et al., 1999</xref>
###xml 918 936 918 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib26">Maeda et al., 1999</xref>
###xml 1758 1773 1754 1769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">An et al., 2008</xref>
###xml 1847 1851 1843 1847 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 1851 1854 1847 1850 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
Recent studies have suggested several feedback regulators for TLR9 activation, including SOCS1 (Rothlin et al., 2007), ATF3 (Whitmore et al., 2007), IRF-4 (Martin et al., 2007), and SHP-1 (An et al., 2008). For example, receptor tyrosine-based activation motif-induced, SOCS1-mediated feedback regulation seems to occur at later stages, such as hours, after TLR9 activation, followed by inflammatory cytokine induction (Rothlin et al., 2007). In contrast, the PIR-B-mediated suppression revealed in this study seems to take place as early as 5 min after CpG-B addition to B-1 cells. Therefore, PIR-B does not seem to fit well into the category of feedback regulatory elements for TLR9. Rather, it plays an important regulatory role in immediate-early cellular responses to TLR9 activation. PIR-B is constitutively tyrosine phosphorylated at the ITIMs and associates with SHP-1 (Ho et al., 1999; Kubagawa et al., 1999; Maeda et al., 1999), which is critical for maintaining steady-state levels of intracellular phosphotyrosylated proteins. In this study, we found a novel and immediately initiated regulatory circuit for TLR9, namely that PIR-B phosphorylation is immediately augmented by TLR9-initiated Lyn activation, and the concomitant enhancement of SHP-1 recruitment to augmented phospho-ITIMs of PIR-B leads to Btk dephosphorylation, which then attenuates the phosphorylation level of NF-kappaB p65RelA. The molecular mechanism for the TLR9-initiated Lyn activation, which augments Btk phosphorylation, is currently not known. Interestingly, on the other hand, SHP-1 has recently been demonstrated to be a critical regulator for type I interferon production by macrophages and dendritic cells through inhibition of IRAK1 activation downstream of TLR4 (An et al., 2008), whereas augmented IRAK1 activation is not observed in CpG-B-stimulated Pirb-/- B-1 cells (), suggesting that B-1 cells preferentially use Btk as a key intersecting molecule for the inhibitory circuit.
###end p 33
###begin p 34
###xml 112 130 112 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib9">Doyle et al., 2007</xref>
###xml 132 152 132 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">Gilliet et al., 2008</xref>
###xml 302 320 298 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib9">Doyle et al., 2007</xref>
###xml 322 338 318 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">Lee et al., 2008</xref>
###xml 536 539 532 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xid</italic>
###xml 615 635 611 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">Bradley et al., 1994</xref>
###xml 637 659 633 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">Hashimoto et al., 1996</xref>
###xml 540 544 <span type="species:ncbi:10090">mice</span>
###xml 549 554 <span type="species:ncbi:9606">human</span>
Recent studies have shown that Btk is an important mediator for the TLR9 cascade in addition to MyD88 and TRAF (Doyle et al., 2007; Gilliet et al., 2008). Btk is required for NF-kappaB activation, participating in the pathway leading to increased phosphorylation of p65RelA activated by TLR8 and TLR9 (Doyle et al., 2007; Lee et al., 2008). As is well known, Btk is a critical kinase for the development and function of B cells, including B-1 cells, by assuring antigen receptor signaling, as has been demonstrated in immunocompromised Xid mice and human X-linked agammaglobulinemia, in which Btk is dysfunctional (Bradley et al., 1994; Hashimoto et al., 1996). Our current finding that Btk is a critical link between the TLR9 cascade and the PIR-B-mediated regulatory loop, particularly in B-1 cells expressing abundant PIR-B (Fig. S3 A), provides an insight into the mechanism underlying crosstalk of the innate immune system with ITIM-harboring receptors.
###end p 34
###begin p 35
###xml 1773 1793 1773 1793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib41">Wheadon et al., 2002</xref>
###xml 1795 1813 1795 1813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib40">Ujike et al., 2002</xref>
###xml 1815 1836 1815 1836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib32">Nakamura et al., 2004</xref>
###xml 1838 1858 1838 1858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib35">Pereira et al., 2004</xref>
###xml 1860 1878 1860 1878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib44">Zhang et al., 2005</xref>
###xml 1880 1899 1880 1899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib29">Masuda et al., 2007</xref>
###xml 2026 2047 2026 2047 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib32">Nakamura et al., 2004</xref>
###xml 2254 2272 2254 2272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib37">Rudge et al., 2002</xref>
###xml 2459 2463 2459 2463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 2463 2466 2463 2466 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2473 2494 2473 2494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib32">Nakamura et al., 2004</xref>
###xml 2467 2471 <span type="species:ncbi:10090">mice</span>
Given that PIR-B might be a negative regulator for TLR9 in B-1 cells, PIR-B-mediated inhibition of TLR9 activation could become potentially harmful for host mammals if their immune system should engage with invading pathogens that otherwise would cause serious infectious diseases. Therefore, it is expected that this regulatory system might be tightly controlled during the course of the capture, sensing, processing, and elimination of virulent microbes. How is PIR-B-initiated TLR9 regulation controlled? Although we do not currently have an answer to this question, it is conceivable that cell-surface expression of PIR-B might be down-regulated or the expression of PIR-A with possibly the opposite function, namely the activation of TLR9, might be up-regulated, or both. Another possibility is that spatial communication between PIR-B and TLR9 on, or near, the cell membrane might be uncoupled during serious infections by means of any unknown intracellular mechanism that controls the dynamics of endosomal/lysosomal TLR9 as well as the dynamics of PIR-B. It may be possible that PIR-B on plasma membrane could translocate partially to the endosomal/lysosomal compartment of B-1 cells upon CpG stimulation. Our preliminary confocal laser-scanning microscopic analysis of B-1 cells stimulated with CpG suggests that it could be the case (). Such translocation may account for, at least partly, the reason why endosomal/lysosomal TLR9 can communicate intimately with PIR-B in terms of CpG-initiated, TLR9-mediated signaling and may imply a presence of any uncoupling mechanism for the TLR9-PIR-B communication. On the other hand, although preceding studies have demonstrated the critical roles of inhibition mediated by PIR-B in the maintenance of immune homeostasis (Wheadon et al., 2002; Ujike et al., 2002; Nakamura et al., 2004; Pereira et al., 2004; Zhang et al., 2005; Masuda et al., 2007), the function of the activating counterpart, PIR-A, remains to be determined, but it also can bind to MHC class I molecules (Nakamura et al., 2004). Control mechanisms for balanced, or in some cases unbalanced, PIR-B and PIR-A gene expression are also not known. One notable observation is that PIR-B expression on activated B cells is reduced by IL-4 (Rudge et al., 2002). Another interesting notion is that PIR-A expression on host dendritic cells is significantly augmented during the induction phase of experimental acute graft-versus-disease induced in Pirb-/- mice (Nakamura et al., 2004). Obviously, we need more precise knowledge on the regulation of PIR-A and PIR-B, and the spatial communication between membrane PIR-B and endosomal/lysosomal TLR9.
###end p 35
###begin p 36
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 161 179 161 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib15">Hardy et al., 1987</xref>
###xml 181 200 181 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib38">Sowden et al., 1987</xref>
###xml 202 222 202 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib43">Youinou et al., 1990</xref>
###xml 233 234 233 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 364 387 364 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib24">Leadbetter et al., 2002</xref>
###xml 479 503 479 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib20">Izui and Eisenberg, 1980</xref>
###xml 642 662 642 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">Gyotoku et al., 1987</xref>
###xml 707 711 707 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 711 714 711 714 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 717 720 717 720 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 714 720 714 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fas<sup>lpr</sup></italic>
###xml 1320 1333 1320 1333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib33">Newkirk, 2002</xref>
###xml 721 725 <span type="species:ncbi:10090">mice</span>
CD5+ B-1 cells are considered to be involved in some autoimmune diseases in which RF is frequently detected or RF production is directly coupled to the disease (Hardy et al., 1987; Sowden et al., 1987; Youinou et al., 1990). Also, RF+ B cells are effectively activated via the IgG2a-chromatin immune complex and synergistic stimulation of TLR9-mediated signaling (Leadbetter et al., 2002). It is known that RF can bind to anti-dsDNA autoantibodies and can form immune complexes (Izui and Eisenberg, 1980). Also, it has been reported that RF itself has cryoglobulin activity and causes glomerulonephritis without any other additional factors (Gyotoku et al., 1987). Our observations on glomerulonephritis in Pirb-/-Faslpr mice with markedly and specifically elevated IgM- and IgG-RF productions, but not other autoantibodies examined, suggest that IgM- and IgG-RF autoantibodies, namely anti-IgG Fc antibodies, are factors that worsen the disease, presumably by accelerating the deposition of IgG autoantibodies against basement membranes of glomeruli. Considering these observations, it may increasingly become important to manipulate the PIR-B-mediated inhibitory system in the regulation of autoimmune diseases while maintaining the integrity of TLR9-mediated microbial sensing, in such cases as rheumatoid arthritis (Newkirk, 2002). Understanding of the PIR-B system in B-1 cells may lead to the development of novel and effective ways toward controlling autoimmune diseases.
###end p 36
###begin title 37
MATERIALS AND METHODS
###end title 37
###begin title 38

###end title 38
###begin title 39
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice.
###end title 39
###begin p 40
###xml 66 70 66 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 70 73 70 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 95 113 95 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib40">Ujike et al., 2002</xref>
###xml 164 168 164 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 168 171 168 171 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 174 177 174 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 171 177 171 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fas<sup>lpr</sup></italic>
###xml 216 219 216 219 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 213 219 213 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fas<sup>lpr</sup></italic>
###xml 243 250 243 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr/lpr</italic>
###xml 284 288 284 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 288 291 288 291 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 359 363 359 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tlr9</italic>
###xml 363 366 363 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 13 17 <span type="species:ncbi:10090">mice</span>
###xml 74 78 <span type="species:ncbi:10090">mice</span>
###xml 139 143 <span type="species:ncbi:10090">mice</span>
###xml 178 182 <span type="species:ncbi:10090">mice</span>
###xml 220 224 <span type="species:ncbi:10090">mice</span>
###xml 292 296 <span type="species:ncbi:10090">mice</span>
###xml 368 372 <span type="species:ncbi:10090">mice</span>
###xml 419 423 <span type="species:ncbi:10090">Mice</span>
###xml 859 863 <span type="species:ncbi:10090">mice</span>
C57BL/6 (B6) mice were purchased from Charles River Laboratories. Pirb-/- mice were generated (Ujike et al., 2002) and backcrossed with B6 mice for 12 generations. Pirb-/-Faslpr mice were generated by crossing B6.Faslpr mice (C57BL/6J Jms Slc-lpr/lpr; The Jackson Laboratory) with B6.Pirb-/- mice and by intercrossing between the littermates. TLR9-deficient (Tlr9-/-) mice were purchased from Oriental BioService, Inc. Mice were maintained and bred in the Animal Facility of the Institute of Development, Aging, and Cancer, Tohoku University, an environmentally controlled and specific pathogen-free facility, according to guidelines for experimental animals defined by the university, and animal protocols were reviewed and approved by the Animal Studies Committee of the university. All experiments were performed on 6-50-wk-old age-matched male and female mice.
###end p 40
###begin title 41
Reagents and antibodies.
###end title 41
###begin p 42
###xml 115 116 115 116 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 734 739 <span type="species:ncbi:10090">mouse</span>
###xml 827 838 <span type="species:ncbi:3704">horseradish</span>
LPS (B8) was purchased from Sigma-Aldrich. Poly(I:C) and ssRNA/LyoVec were obtained from InvivoGen. Anti-IgM F(ab')2 was purchased from Invitrogen. Phosphothioate-CpG-B oligodeoxynucleotide (ODN1826; 5'-TCCATGACGTTCCTGACGTT-3') and phosphothioate-GpC (5'-TCCATGAGCTTCCTGAGCTT-3') were synthesized by Hokkaido System Science Co., Ltd. Src kinase inhibitors SU6656 and PP2 were obtained from EMD. Antibodies to phospho-Syk (Tyr352), Syk, Lyn, phospho-p44/42 MAPK (Thr202/Tyr204 and D13.14.4E), phospho-p38 (Thr180/Tyr182), p38 (5F11), phospho-NF-kB p65 (Ser536), and NF-kappaB p65 were obtained from Cell Signaling Technology. Phospho-Btk (Tyr550) antibody was obtained from Abcam. Antibodies to Btk, Erk, PIR-B (p91), anti-IRAK1, anti-mouse monoclonal Btk (E-9), and SHP-1 were purchased from Santa Cruz Biotechnology, Inc. The horseradish peroxidase (HRP)-conjugated antiphosphotyrosine mAb (RC20) was purchased from BD. The antibody to beta-actin was obtained from Sigma-Aldrich.
###end p 42
###begin title 43
Cell separation.
###end title 43
###begin p 44
###xml 39 40 39 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 483 484 479 480 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 489 490 485 486 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 617 618 613 614 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 623 624 619 620 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 322 327 <span type="species:ncbi:10090">mouse</span>
For separation of splenic B cells, B220+ cells were purified with a magnetic-activated cell sorter (MACS; Miltenyi Biotec). For preparation of peritoneal B-1 cells, peritoneal cells were isolated by washing of the peritoneal cavity with ice-cold RPMI 1640 containing 10% FCS. Peritoneal cells were first blocked with anti-mouse FcgammaR mAb (2.4G2; BD) and then stained with allophycocyanin (APC)-labeled anti-B220 (RA3-6B2; BD) and FITC-labeled anti-CD11b (M1/70; BD) mAbs, and B220+CD11b+ cells were sorted using a FACSAria (BD). The purity of the sorted populations was consistently >95%, as determined by the B220+CD11b+ phenotype. Bone marrow cells from femurs were cultured in alpha-MEM containing 10% FCS and 20 ng/ml M-CSF (PeproTech) at 37degreesC. After 7 d, the adherent cells were used as bone marrow-derived macrophages (BMMs).
###end p 44
###begin title 45
Proliferation assay.
###end title 45
###begin p 46
###xml 2 3 2 3 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 41 42 41 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 348 349 348 349 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
105 splenic B cells per well and 2.5 x 104 peritoneal B-1 cells per well were cultured in 96-well flat plates (Corning) with RPMI 1640 containing 10% FCS, 1 mM sodium pyruvate, and supplemented antibiotics. The cells were activated with the reagents described in Reagents and antibodies. After 48 h of stimulation, proliferation was determined as [3H]thymidine uptake.
###end p 46
###begin title 47
Measurement of antibodies and a cytokine.
###end title 47
###begin p 48
###xml 6 7 6 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 259 264 <span type="species:ncbi:10090">mouse</span>
###xml 319 324 <span type="species:ncbi:10090">mouse</span>
###xml 366 371 <span type="species:ncbi:10090">mouse</span>
###xml 436 441 <span type="species:ncbi:10090">mouse</span>
###xml 487 491 <span type="species:ncbi:10090">mice</span>
###xml 666 671 <span type="species:ncbi:10090">mouse</span>
5 x 104 peritoneal B-1 cells per well were cultured in 96-well flat plates with or without stimulants. The supernatants of 20-72-h-cultured peritoneal B-1 cells were collected, and the amounts of anti-dsDNA antibodies, RF, IgM, and IL-10 were determined with mouse anti-dsDNA and anti-ssDNA ELISA kits (Shibayagi Co.), mouse IgM and IgG RF ELISA kits (Shibayagi), a mouse IgM ELISA quantification kit (Bethyl Laboratories, Inc.), and a mouse IL-10 ELISA MAX (BioLegend). Serum from aged mice was collected, and the amounts of anti-dsDNA antibodies, total IgM, and RF were determined by ELISA as described. The amount of anti-SS-B/La antibodies was determined with a mouse anti-SSB/La antibodies ELISA kit (Alpha Diagnostic Intl. Inc.).
###end p 48
###begin title 49
Immunoprecipitation analysis.
###end title 49
###begin p 50
###xml 394 399 <span type="species:ncbi:10090">mouse</span>
###xml 740 744 <span type="species:ncbi:9925">goat</span>
###xml 750 756 <span type="species:ncbi:9986">rabbit</span>
###xml 1011 1017 <span type="species:ncbi:9986">rabbit</span>
###xml 1023 1027 <span type="species:ncbi:9925">goat</span>
###xml 1061 1067 <span type="species:ncbi:9986">rabbit</span>
Peritoneal cells, peritoneal B-1 cells, and BMMs were incubated for 0, 5, or 30 min at 37degreesC with 1 microM CpG-B. Cells were solubilized in a lysis buffer (0.75% Briji-97, 50 mM Hepes [pH 7.4], 100 mM NaCl, and 10% glycerol) containing 2 mM sodium vanadate and supplemented with protease inhibitors. Cell lysates were incubated with Dynabeads protein A (Invitrogen) preincubated with anti-mouse PIR-B (p91; Santa Cruz Biotechnology, Inc.) or anti-Lyn (Cell Signaling Technology). The immunoprecipitates were separated in an SDS-PAGE gel, transferred to a polyvinylidene difluoride (PVDF) membrane (Millipore), and detected with the HRP-antiphosphotyrosine mAb (RC20; BD), anti-SH-PTP-1 (Santa Cruz Biotecnology, Inc.), and HRP-labeled goat anti-rabbit IgG (Cell Signaling Technology) using an enhanced chemiluminescence system (GE Healthcare). The membranes were stripped off with a stripping buffer comprising 62.5 mM Tris (pH 6.8), 100 mM 2-ME, and 2% SDS, and reprobed with anti-p91 or anti-Lyn and HRP-rabbit anti-goat IgG (Millipore) or TrueBlot anti-rabbit IgG HRP (eBioscience).
###end p 50
###begin title 51
Immunoblot analysis.
###end title 51
###begin p 52
Peritoneal B-1 cells were solubilized in a lysis buffer (1% NP-40, 20 mM Tris [pH 7.3], 150 mM NaCl, 10 mM EDTA, and 10% glycerol) containing 2 mM sodium vanadate and 50 mM sodium fluoride, and supplemented with protease inhibitors. Cell lysates were separated by SDS-PAGE and transferred to a PVDF membrane, followed by detection with the appropriate antibodies. Signal intensities of each protein were estimated by densitometric scanning (Dolphin View band tool; KURABO).
###end p 52
###begin title 53
Flow cytometry.
###end title 53
###begin p 54
###xml 563 564 559 560 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 144 149 <span type="species:ncbi:10090">mouse</span>
###xml 256 259 <span type="species:ncbi:10116">rat</span>
###xml 275 278 <span type="species:ncbi:10116">rat</span>
###xml 364 369 <span type="species:ncbi:10090">mouse</span>
###xml 539 543 <span type="species:ncbi:9925">goat</span>
###xml 549 552 <span type="species:ncbi:10116">rat</span>
###xml 927 932 <span type="species:ncbi:10090">mouse</span>
###xml 994 1000 <span type="species:ncbi:9986">rabbit</span>
###xml 1006 1011 <span type="species:ncbi:10090">mouse</span>
###xml 1095 1099 <span type="species:ncbi:9925">goat</span>
###xml 1105 1111 <span type="species:ncbi:9986">rabbit</span>
For flow cytometric analysis, the following mAbs obtained from BD were used: purified FITC-, PE-, APC-, or biotin-conjugated antibodies against mouse B220 (RA3-6B2), IgM (R6-60.2), IgD (11-26), CD3 (145-2C11), CD5 (Ly-1), CD11b (M1/70), and CD138 (281-2); rat IgG1 (A101-1); rat IgG2a (R35-95); PECy5-conjugated streptavidin; APC-conjugated streptavidin; and anti-mouse FcgammaR (2.4G2). For PIR-B staining, peritoneal cells or splenocytes were stained with anti-PIR-A/B (6C1; BD). After washing, the cells were stained with PE-conjugated goat anti-rat IgG F(ab')2 antibody (AbD Serotec). After washing, the cells were stained with the appropriate antibodies for the surface antigens of B cells. For intracellular TLR9 or Btk staining, peritoneal cells or splenocytes were fixed with Cytofix/Cytoperm (BD). After cells had been washed in a permeabilization buffer (Perm/Wash; BD), they were stained with biotin-conjugated anti-mouse TLR9 (M9.D6; eBioscience) and APC-conjugated streptavidin or rabbit anti-mouse Btk antibody (M-138; Santa Cruz Biotechnology Inc.) and Alexa Fluor 647-conjugated goat anti-rabbit IgG (Invitrogen). Cell surfaces were stained by standard techniques, and flow cytometry was performed with a FACSCalibur (BD) and analyzed with FlowJo software (Tree Star, Inc.).
###end p 54
###begin title 55
Reduction of peritoneal B cells.
###end title 55
###begin p 56
###xml 73 95 73 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">Murakami et al. (1995)</xref>
###xml 35 39 <span type="species:ncbi:10090">mice</span>
###xml 208 212 <span type="species:ncbi:10090">mice</span>
###xml 278 282 <span type="species:ncbi:10090">mice</span>
For peritoneal B cell reduction in mice, we used the method described by Murakami et al. (1995). In brief, distilled water or PBS, as a negative control, was injected every week into the peritoneal cavity of mice. The doses of injected water and PBS depended on the size of the mice as follows: 1 ml for 4-8 wk of age or 2 ml for 8 wk of age and older. Blood was collected after the fourth injection of water or PBS.
###end p 56
###begin title 57
Histological study and immunohistochemistry.
###end title 57
###begin p 58
###xml 831 835 821 825 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 835 838 825 828 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 843 846 833 836 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 840 846 830 836 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fas<sup>lpr</sup></italic>
###xml 848 852 838 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 852 855 842 845 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 858 861 848 851 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 855 861 845 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fas<sup>lpr</sup></italic>
###xml 867 873 857 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fcgr2b</italic>
###xml 873 876 863 866 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 879 882 869 872 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 876 882 866 872 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fas<sup>lpr</sup></italic>
###xml 884 903 874 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib45">Yajima et al., 2003</xref>
###xml 547 552 <span type="species:ncbi:10090">mouse</span>
###xml 576 580 <span type="species:ncbi:9925">goat</span>
###xml 597 602 <span type="species:ncbi:10090">mouse</span>
###xml 678 682 <span type="species:ncbi:9925">goat</span>
###xml 905 909 <span type="species:ncbi:10090">mice</span>
###xml 973 978 <span type="species:ncbi:10090">mouse</span>
Kidney samples and foot joints were fixed with 4% neutral-buffered formalin-PBS, embedded in paraffin, sectioned at 2 microm, and stained with PAS or hematoxylin and eosin. To assay for immune complex deposition, formalin-fixed and paraffin-embedded kidney sections were deparaffinized in xylene and dehydrated through a graded ethanol series. After washing with distilled water, sections were incubated with trypsin (Nichirei) for 50 min at 37degreesC and washed three times with PBS. Sections were incubated with Alexa Fluor 488-conjugated anti-mouse IgG, IgM (Invitrogen), goat IgG fraction to mouse complement C3 (Cappel; MP Biomedicals), or Alexa Fluor 488-conjugated anti-goat IgG (Invitrogen). To detect antinuclear antibodies in sera, HEp2 cell plates (FLUORO HEPANA test; MBL International) were stained with sera from B6 Pirb-/-, Faslpr, Pirb-/-Faslpr, and Fcgr2b-/-Faslpr (Yajima et al., 2003) mice at different dilutions, and detected with FITC-conjugated anti-mouse IgG (Cappel; MP Biomedicals). Samples were examined under microscopes (BX50 [Olympus] and VB-7000 [Keyence]).
###end p 58
###begin title 59
Renal function test.
###end title 59
###begin p 60
###xml 11 15 <span type="species:ncbi:10090">mice</span>
Serum from mice of each strain at 40 wk of age was collected, and the amounts of blood urea nitrogen and creatinine were determined with a dry chemistry analyzer (Fujifilm).
###end p 60
###begin title 61
Confocal laser-scanning microscopic analysis.
###end title 61
###begin p 62
###xml 37 38 37 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 45 46 45 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 52 53 52 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 62 63 62 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 73 77 <span type="species:ncbi:10090">mice</span>
###xml 339 344 <span type="species:ncbi:10090">mouse</span>
###xml 362 365 <span type="species:ncbi:10116">rat</span>
MACS-sorted peritoneal B-1 cells (CD3-, F4/80-, CD23-, and IgM+) from B6 mice were cultured with Cy5-conjugated CpG-B (ODN1826; Nihon Gene Research Laboratories Inc.) and LysoTracker Green DND-26 (Invitrogen) for 30 min. After fixation with Cytofix/Cytoperm, cells were permeabilized with Perm/Wash and stained with biotin-conjugated anti-mouse PIR-A/B (6C1) or rat IgG1 isotype control (BD) and Alexa Fluor 546-conjugated streptavidin (Invitrogen). Samples were examined under a microscope (Fluoview FV1000; Olympus).
###end p 62
###begin title 63
Statistical analysis.
###end title 63
###begin p 64
###xml 84 85 84 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
Statistical analyses were performed using two-way analysis of variance or Student's t test. P < 0.05 is considered as statistically significant.
###end p 64
###begin title 65
Online supplemental material.
###end title 65
###begin p 66
###xml 114 117 114 117 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 111 117 111 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fas<sup>lpr</sup></italic>
###xml 307 311 304 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 311 314 308 311 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 926 930 923 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 930 933 927 930 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 938 942 935 939 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pirb</italic>
###xml 942 945 939 942 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 948 951 945 948 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 945 951 942 948 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fas<sup>lpr</sup></italic>
###xml 315 319 <span type="species:ncbi:10090">mice</span>
###xml 952 956 <span type="species:ncbi:10090">mice</span>
Fig. S1 presents additional data showing that PIR-B deletion leads to renal dysfunction when combined with the Faslpr mutation but does not have an impact on arthritis development, or antinuclear, anti-SS-B/La, and anti-beta2-GPI autoantibody production. Fig. S2 shows diminishment of peritoneal B cells in Pirb-/- mice by repeated water injection. Fig. S3 shows that peritoneal B-1 cells express much more PIR-B than splenic B-2 cells, that TLR9 expression does not differ between B-1 and B-2 cells, and that Btk expression is higher in B-1 than B-2 cells. Fig. S4 shows that PIR-A expression is not detected on B-1 cells and that TLR9 expression does not change. Fig. S5 shows that the IRAK1 degradation level was not significantly altered in PIR-B-deficient B-1 cells. Fig. S6 shows that PIR-B can translocate into the endolysosomal compartment after CpG-B stimulation of B-1 cells. Table S1 presents hematocrit values for Pirb-/- and Pirb-/-Faslpr mice. Online supplemental material is available at .
###end p 66
###begin title 67
Supplementary Material
###end title 67
###begin title 68
[Supplemental Material]
###end title 68
###begin p 69
We thank N. Halewood for editorial assistance, and Y. Ito and A. Sugahara-Tobinai for the outstanding technical support.
###end p 69
###begin p 70
This work was supported in part by the Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency, a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, the Kanae Foundation for the Promotion of Medical Science, and a grant from the 21st Century Center of Excellence (COE) Program for Innovative Therapeutic Development Toward the Conquest of Signal Transduction Diseases and the Global COE Program for Network Medicine.
###end p 70
###begin p 71
The authors have no conflicting financial interest.
###end p 71
###begin article-title 72
Toll-like receptors: critical proteins linking innate and acquired immunity.
###end article-title 72
###begin article-title 73
Phosphatase SHP-1 promotes TLR- and RIG-I-activated production of type I interferon by inhibiting the kinase IRAK1.
###end article-title 73
###begin article-title 74
TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity.
###end article-title 74
###begin article-title 75
B-1 B cells: development, selection, natural autoantibody and leukemia.
###end article-title 75
###begin article-title 76
Origins and functions of B-1 cells with notes on the role of CD5.
###end article-title 76
###begin article-title 77
Mutation detection in the X-linked agammaglobulinemia gene, BTK, using single strand conformation polymorphism analysis.
###end article-title 77
###begin article-title 78
Innate autoimmunity.
###end article-title 78
###begin article-title 79
Type II mixed cryoglobulinaemia as an oligo rather than a mono B-cell disorder: evidence from GeneScan and MALDI-TOF analyses.
###end article-title 79
###begin article-title 80
Signaling by Toll-like receptors 8 and 9 requires Bruton's tyrosine kinase.
###end article-title 80
###begin article-title 81
TLR agonists selectively promote terminal plasma cell differentiation of B cell subsets specialized in thymus-independent responses.
###end article-title 81
###begin article-title 82
Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases.
###end article-title 82
###begin article-title 83
BAFF and MyD88 signals promote a lupuslike disease independent of T cells.
###end article-title 83
###begin article-title 84
###xml 61 67 <span type="species:ncbi:10090">murine</span>
Toll-like receptor expression and responsiveness of distinct murine splenic and mucosal B-cell subsets.
###end article-title 84
###begin article-title 85
###xml 107 114 107 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr/lpr</italic>
###xml 115 119 <span type="species:ncbi:10090">mice</span>
Cryoglobulinemia induced by monoclonal immunoglobulin G rheumatoid factors derived from autoimmune MRL/MpJ-lpr/lpr mice.
###end article-title 85
###begin article-title 86
###xml 44 45 44 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 33 38 <span type="species:ncbi:9606">human</span>
Rheumatoid factor secretion from human Leu-1+ B cells.
###end article-title 86
###begin article-title 87
Identification of Bruton's tyrosine kinase (Btk) gene mutations and characterization of the derived proteins in 35 X-linked agammaglobulinemia families: a nationwide study of Btk deficiency in Japan.
###end article-title 87
###begin article-title 88
###xml 29 35 <span type="species:ncbi:10090">murine</span>
Molecular cloning of a novel murine cell-surface glycoprotein homologous to killer cell inhibitory receptors.
###end article-title 88
###begin article-title 89
Constitutive tyrosine phosphorylation of the inhibitory paired Ig-like receptor PIR-B.
###end article-title 89
###begin article-title 90
Toll-like receptor control of the adaptive immune responses.
###end article-title 90
###begin article-title 91
###xml 58 62 <span type="species:ncbi:10090">mice</span>
Circulating anti-DNA-rheumatoid factor complexes in MRL/1 mice.
###end article-title 91
###begin article-title 92
Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity.
###end article-title 92
###begin article-title 93
A novel pair of immunoglobulin-like receptors expressed by B cells and myeloid cells.
###end article-title 93
###begin article-title 94
Biochemical nature and cellular distribution of the paired immunoglobulin-like receptors, PIR-A and PIR-B.
###end article-title 94
###begin article-title 95
Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors.
###end article-title 95
###begin article-title 96
Bruton's tyrosine kinase separately regulates NFkappaB p65RelA activation and cytokine interleukin (IL)-10/IL-12 production in TLR9-stimulated B Cells.
###end article-title 96
###begin article-title 97
Paired immunoglobulin-like receptor B (PIR-B) inhibits BCR-induced activation of Syk and Btk by SHP-1.
###end article-title 97
###begin article-title 98
Toll-like receptors: paving the path to T cell-driven autoimmunity?
###end article-title 98
###begin article-title 99
###xml 62 80 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Manipulation of the toll-like receptor 7 signaling pathway by Epstein-Barr virus.
###end article-title 99
###begin article-title 100
Cis binding between inhibitory receptors and MHC class I can regulate mast cell activation.
###end article-title 100
###begin article-title 101
New perspectives in B-1 B cell development and function.
###end article-title 101
###begin article-title 102
###xml 54 58 <span type="species:ncbi:10090">mice</span>
Prevention of autoimmune symptoms in autoimmune-prone mice by elimination of B-1 cells.
###end article-title 102
###begin article-title 103
###xml 49 53 <span type="species:ncbi:10090">mice</span>
Exacerbated graft-versus-host disease in Pirb-/- mice.
###end article-title 103
###begin article-title 104
Rheumatoid factors: host resistance or autoimmunity?
###end article-title 104
###begin article-title 105
Control of early viral and bacterial distribution and disease by natural antibodies.
###end article-title 105
###begin article-title 106
The inhibitory receptor PIR-B negatively regulates neutrophil and macrophage integrin signaling.
###end article-title 106
###begin article-title 107
TAM receptors are pleiotropic inhibitors of the innate immune response.
###end article-title 107
###begin article-title 108
Interleukin 4 reduces expression of inhibitory receptors on B cells and abolishes CD22 and FcgammaRII-mediated B cell suppression.
###end article-title 108
###begin article-title 109
###xml 66 74 <span type="species:ncbi:9606">patients</span>
Evaluation of CD5-positive B cells in blood and synovial fluid of patients with rheumatic diseases.
###end article-title 109
###begin article-title 110
Unraveling B-1 progenitors.
###end article-title 110
###begin article-title 111
###xml 79 83 <span type="species:ncbi:10090">mice</span>
Impaired dendritic cell maturation and increased T(H)2 responses in PIR-B(-/-) mice.
###end article-title 111
###begin article-title 112
Molecular interactions of SHP1 and SHP2 in IL-3-signalling.
###end article-title 112
###begin article-title 113
Negative regulation of TLR-signaling pathways by activating transcription factor-3.
###end article-title 113
###begin article-title 114
FcgammaRIIB deficiency with Fas mutation is sufficient for the development of systemic autoimmune disease.
###end article-title 114
###begin article-title 115
###xml 106 114 <span type="species:ncbi:9606">patients</span>
The relationship between CD5-expressing B lymphocytes and serologic abnormalities in rheumatoid arthritis patients and their relatives.
###end article-title 115
###begin article-title 116
The Src family kinases Hck and Fgr negatively regulate neutrophil and dendritic cell chemokine signaling via PIR-B.
###end article-title 116
###begin p 117
###xml 110 121 <span type="species:ncbi:3704">horseradish</span>
Abbreviations used: beta2-GPI, beta2-glycoprotein I; Btk, Bruton's tyrosine kinase; ds, double stranded; HRP, horseradish peroxidase; ITIM, immunoreceptor tyrosine-based inhibitory motif; MAPK, mitogen-activated protein kinase; PAS, periodic acid-Schiff; PIR-B, paired Ig-like receptor B; PVDF, polyvinylidene difluoride; RF, rheumatoid factor; SHP-1, SH2 domain-containing tyrosine phosphatase 1; ss, single stranded; TLR, Toll-like receptor.
###end p 117

